API & Excipients
Our portfolio covers high-quality Active Pharmaceutical Ingredients, intermediates and functional excipients for low-volume / high-value (LVHV) dosage forms. Therapeutic areas of strength:
- Anti-diabetics (SGLT-2, GLP-1 analogues)
- Oncology (small-molecule TKIs, cytotoxics, ADC payloads)
- CNS & multiple sclerosis therapies
- Hormones & peptides
- Controlled substances (Schedules II–V) with full chain-of-custody
All materials are:
- GMP-certified and accompanied by CEP, ASMF or DMF filings
- Tested to Ph. Eur., USP-NF or in-house validated methods
- Supplied with complete CoA, stability data, residual-solvent profiles and elemental-impurity reports
- Offered at competitive pricing without hidden freight or handling surcharges
product list
Diabetes Mellitus
- Dapagliflozin Propandiol Monohydrate (CAS 960404-48-2) – API – GMP/CTD Available
- Empagliflozin (CAS 864070-44-0) – API – GMP/CTD Available
- Linagliptin (CAS 668270-12-0) – API – GMP/CTD Available
- Sitagliptin Phosphate Monohydrate (CAS 654671-77-9) – API – GMP/CTD Available
- Tirzepatide (CAS 2023788-19-2) – API – GMP/CTD Available
Cardiovascular
- Apixaban (CAS 503612-47-3) – API & Granule – GMP/CTD Available
- Rivaroxaban (CAS 366789-02-8) – API & Granule – GMP/CTD Available
- Sacubitril / Valsartan (CAS 936623-90-4) – API & Granule – GMP/CTD Available
- Ticagrelor (CAS 274693-27-5) – API & Granule – GMP/CTD Available
Oncology
- Abemaciclib (CAS 1231929-97-7) – API – Available
- Abiraterone Acetate (CAS 154229-18-2) – API & Granule – Available
- Capecitabine (CAS 154361-50-9) – API – Scheduled
- Crizotinib (CAS 877399-52-5) – API – Available
- Dabrafenib Mesylate, Dasatinib (Anhydrous/Monohydrate), Erlotinib HCl, Gefitinib, Ibrutinib, Imatinib Mesylate, Letrozole, Lenalidomide Hemihydrate, Lenvatinib Mesylate, Nilotinib HCl Monohydrate, Olaparib, Osimertinib Mesylate, Palbociclib, Pazopanib HCl, Regorafenib Monohydrate, Ruxolitinib Phosphate, Sorafenib Tosylate, Sunitinib Malate, Trametinib DMSO, Vandetanib, Venetoclax
Multiple Sclerosis
- Dimethyl Fumarate (CAS 624-49-7) – API – Available
- Diroximel Fumarate (CAS 1577222-14-0) – API – Available
- Fingolimod HCl (CAS 162359-56-0) – API – Available
- Ozanimod HCl (CAS 1618636-37-5) – API – Available
- Siponimod Fumarate (CAS 1234627-85-0) – API – Available
- Teriflunomide (CAS 163451-81-8) – API – Available
Others
- Desloratadine (CAS 100643-71-8) – API – Available
- Roxadustat (CAS 808118-40-3) – API – Available
- Tofacitinib Citrate (CAS 540737-29-9) – API & Granule – Available
- Voriconazole (CAS 137234-62-9) – API – Available
- Vonoprazan Fumarate (CAS 881681-01-2) – API – Scheduled
- Bilastine (CAS 202189-78-4) – API & Granule – Scheduled
- Resmetirome (CAS 920509-32-6) – API & Granule – Scheduled